Laigo Bio completes final close of oversubscribed seed financing of 17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs
Additional funding of €4m from new co-lead investor Biovance Capital, and €1.5m…
Cellebrite Launches Guardian Investigate, the AI-Powered Nerve Center that Revolutionizes How Investigative Teams Close Cases
Investigators and AI agents together resolve cases faster across departments and agenciesTYSONS…
Navi Finserv convenes close to 200 financial sector leaders at the 3rd Navi Lenders Summit 2026
Strengthens partnerships with close to ₹16,000 crore raised since April 2025 across…
Persevere Therapeutics Launches as a Clinical-Stage Oncology Company with a Novel Phase 1b/2a Agent and Announces First Close of Seed Financing
Chesterbrook, PA, March 03, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. (“Persevere”),…
LANZAJET ANNOUNCES $47M IN NEW CAPITAL AND FIRST CLOSE OF EQUITY ROUND AT $650M PRE-MONEY VALUATION – FURTHER VALIDATING LANZAJET’S SAF TECHNOLOGY AND ENABLING GROWTH
International Airlines Group (IAG), Shell, Groupe ADP, LanzaTech, and Mitsui make additional…
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investorsStephen…
BioNTX Marks the Close of the First Quarter of the 21st Century with Growth, Workforce Momentum, and Innovation Leadership
IRVING, Texas, Dec. 31, 2025 (GLOBE NEWSWIRE) -- As 2025 ends, BioNTX…
NYSE Content Advisory: Pre-Market Update + S&P 500 Powers to Record Close Above 6,900
NEW YORK, Dec. 24, 2025 /PRNewswire/ -- The New York Stock Exchange…
IBSAT 2025 Applications Close Today for MBA/PGPM Admissions to ICFAI Business School’s 9 Campuses
HYDERABAD, India, Dec. 19, 2025 /PRNewswire/ -- The ICFAI Business School (IBS) announced that…
Vaxil Announces Close of Previously Announced Non-Brokered Private Placement and Update on Board of Directors
December 04, 2025 07:00 ET | Source: Vaxil Bio Ltd. Not for…
